Key facts
- It has raised $13.7M; the latest was Early Stage VC in Feb 2026.
- Notable investors include Shanghai Lingang Economic Development, Suzhou Yuanfeng Capital Management, PICC Capital, BC Global Asset Management, Ningbo Junan Holdings — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Lungshield Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Lungshield Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lungshield Medical
Manufacturer of artificial lungs based on RAS-Q technology. The company focuses on the research, development, and industrialisation of life support system products, providing advanced blood gas exchange devices for patients with varying degrees of chronic obstructive pulmonary disease.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2018
- Employees
- 40
- Website
- lungshield-medical.com/
- Ownership
- Privately Held (backing)
Lungshield Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lungshield Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lungshield Medical in its N-PORT filings yet. We sweep new filings monthly.